Virafin 100mg Injection

About

Virafin 100mg Injection contains Peginterferon alfa-2b, a pegylated form of interferon alfa-2b, which is an immunomodulatory protein. This medication works by binding to specific receptors on cell surfaces, initiating a cascade of intracellular events that lead to the expression of various interferon-stimulated genes. These genes produce proteins that inhibit viral replication, modulate immune responses, and exert antiproliferative effects. The pegylation process extends the drug's half-life, allowing for less frequent dosing compared to non-pegylated interferons, thereby improving patient convenience and adherence.

It is primarily used in the treatment of chronic viral infections, such as hepatitis B and C, and certain types of cancers. Its mechanism involves enhancing the body's natural defense mechanisms against viruses and inhibiting the growth of cancer cells. The clinical efficacy of Peginterferon alfa-2b has been demonstrated in achieving sustained virological response in hepatitis patients and contributing to disease control in specific oncological settings.

Uses

• Treatment of chronic hepatitis C.
• Treatment of chronic hepatitis B.
• Adjuvant therapy for melanoma.
• Treatment of certain types of leukemia.

Directions For Use

Administered via subcutaneous injection, typically once weekly, as directed by a physician.

Benefits

• Sustained virological response in hepatitis.
• Reduced viral load in chronic infections.
• Immunomodulatory and antiviral effects.
• Antiproliferative action against cancer cells.
• Less frequent dosing compared to non-pegylated interferons.
• Improved disease outcomes in specific conditions.

Side Effects

• Flu-like symptoms (fever, chills, myalgia).
• Fatigue and malaise.
• Nausea and vomiting.
• Diarrhea or constipation.
• Anorexia and weight loss.
• Depression and irritability.
• Hair thinning (alopecia).
• Injection site reactions.
• Thyroid dysfunction.
• Myelosuppression (neutropenia, thrombocytopenia).
• Exacerbation of autoimmune disorders.
• Neuropsychiatric effects.

Safety Measures

• Alcohol - Avoid alcohol due to potential for increased liver toxicity and exacerbation of underlying liver disease.
• Pregnancy - Contraindicated in pregnancy due to potential for fetal harm; effective contraception is required.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and cause adverse effects in the infant.
• Liver - Use with caution in patients with severe hepatic impairment; monitor liver function closely.
• Kidney - Dose adjustment may be necessary in patients with moderate to severe renal impairment; monitor kidney function.
• Lung - Use with caution in patients with pre-existing pulmonary disease; monitor for respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.